37,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
  • Gebundenes Buch

- Alpha-Adrenergic Blockers
- Alpha2-Adrenergic Agonists
- Angiotensin-Converting Enzyme Inhibitors
- Angiotensin II Receptor Blockers
- Antiarrhythmic Agents
- Antithrombotic Therapy
- Beta-Adrenergic Blockers
- Calcium Antagonists
- Diuretics
- Isotropic and asopressor Agents
- Lipid-Lowering Drugs
- Neuronal and Ganglionic Blockers
- Vasodilators.
This fourth edition of Current Cardiovascular Drugs is designed to provide an updated practical compendium of current knowledge regarding cardiovascular drug therapy in a concise, easily readable format. The
…mehr

Produktbeschreibung
- Alpha-Adrenergic Blockers

- Alpha2-Adrenergic Agonists

- Angiotensin-Converting Enzyme Inhibitors

- Angiotensin II Receptor Blockers

- Antiarrhythmic Agents

- Antithrombotic Therapy

- Beta-Adrenergic Blockers

- Calcium Antagonists

- Diuretics

- Isotropic and asopressor Agents

- Lipid-Lowering Drugs

- Neuronal and Ganglionic Blockers

- Vasodilators.
This fourth edition of Current Cardiovascular Drugs is designed to provide an updated practical compendium of current knowledge regarding cardiovascular drug therapy in a concise, easily readable format. The book is organized into chapters by drug class, and details the pharmacologic characteristics of specific treatment entities. The clinical efficacy and limitations of the various drug therapies are discussed using supportive reference material from the most authoritative sources and published clinical trials.
Autorenporträt
William H. Frishman, Kaiser Permanente/Los Angeles Medical Center, Placentia, NY, USA / Angela Cheng-Lai, Kaiser Permanente/Los Angeles Medical Center, Placentia, NY, USA / James Nawarskas, Kaiser Permanente/Los Angeles Medical Center, Placentia, NY, USA